Recent Finacing
Recent Raise
Symic Bio is a clinical-stage biotech in San Francisco developing extracellular matrix–targeting therapeutics, advancing SB-030 for vascular graft/AVF applications and SB-061 for osteoarthritis.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Symic Biomedical.
